InTest Reports Strong Second Quarter 2026 Revenue of $35.3 Million, EPS of $0.04, and Adjusted EPS (Non-GAAP) of $0.09

InTest Corporation reported Q2 2026 revenue of $35.3M, up 25.5% year over year for the quarter ended June 30, 2026. The strong top-line growth is a clear positive signal for near-term momentum, though the article excerpt does not provide profitability or guidance details.

Analysis

This is more useful as a read-through on semi-capex sentiment than as a standalone earnings story. A small industrial test vendor posting double-digit growth typically matters because it is one of the earlier parts of the equipment stack to reaccelerate when customers move from digestion to incremental buildout; if that is real, the operating leverage can be sharp because fixed manufacturing and SG&A bases are meaningful at this scale. The market will likely try to extrapolate this into a broader recovery for small-cap semi equipment beta, where names like TER, KLAC, AMAT, and SOXX can re-rate if order momentum is confirmed.

The second-order risk is that this kind of print is often lumpy shipment timing rather than durable demand. If the growth is concentrated in one end market or one program, it can reverse quickly when customers normalize inventory or defer qualification cycles; that is especially true in auto/EV and defense, where project timing can distort quarterly comparisons. The key question over the next 1-3 months is whether bookings and backlog confirm the revenue beat; without that, the move is likely to fade once the headline excitement passes.

Contrarianly, the market may be underweight how much small-cap suppliers can outgrow the large-cap tool complex in the early stage of a cycle, but it may also be overweighting the signal quality of a single quarter. For the next 6-18 months, the real upside case is sustained exposure to advanced packaging, test intensity, and re-shoring; the real downside is margin compression from mix or expediting costs if volume is not repeatable. What would falsify the bullish read: flat/declining bookings in the next quarter, guidance that implies one-off shipments, or gross margin that fails to expand despite higher revenue.

Key Decisions for Investors

• Small starter long INTT only on confirmation that the next earnings call shows order growth and backlog conversion; treat this as a 1-3 month catalyst trade, not a structural conviction hold.
• If already long semicap beta, rotate a portion toward INTT versus larger-cap names like AMAT/KLAC only if you want higher operating leverage; expect higher upside in a confirmed capex upswing but materially worse drawdown risk if the cycle rolls.
• Use SOXX as the hedge vehicle for a long INTT position if you want to isolate idiosyncratic execution; the trade works best if INTT outperforms on margin/guide rather than just riding the sector.
• Do not chase the headline if management does not raise full-year expectations on the call; in that case, the stock is likely just front-running a one-quarter shipment bump and should be faded on strength.